History of gastrointestinal symptoms with other glucose-lowering agents is associated with gastrointestinal adverse events after imeglimin initiation: A retrospective real-world study.
Yoshida K, Onishi Y, Kubota T, Yoshida Y, Tahara T, Takase S, Iwamoto M, Nakada R, Aita H, Kasuga M
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.